- September 16, 2020
Yale Researchers to Lead $52M Investigation Into Cause, Effect of Schizophrenia in Some High-risk Adolescents
- June 19, 2020
Yale Child Study Center 2020 Graduates: Research Training Program in Childhood Neuropsychiatric Disorders
- December 09, 2019
Anticevic Recipient of Joel Elkes Research Award
- February 12, 2019
Local variations in circuitry are key to brain’s power
- October 25, 2018
Researchers Explain how LSD Changes Perception
- August 08, 2018
Marriage of imaging and genetics opens new view of brain function
- October 02, 2017
Anticevic, Murray edit new book on computational psychiatry
- April 24, 2017
Anticevic, Murray co-edit special issue in Biological Psychiatry
- February 24, 2017
Delegation of faculty, trainees oppose state budget cuts in testimony
- December 15, 2016
Yale faculty, researchers contribute chapter to book about Computational Psychiatry
- October 27, 2016
Anticevic Lab receives donation from NVIDIA Corporation
- October 05, 2016
New study reveals shift in global brain signals in schizophrenia
- September 15, 2016
Anticevic Lab collaborates on neuroimaging study examining treatment in major depression.
- March 14, 2016
Researcher from University College London to work at Anticevic Lab
- February 25, 2016
Anticevic to receive Society of Biological Psychiatry research award
- December 08, 2015
Anticevic named Rising Star by Schizophrenia International Research Society
- November 16, 2015
Resident, medical student win travel awards to attend conference
- September 15, 2015
Genevieve Yang Awarded F30 Fellowship by NIMH
- August 22, 2015Source: ECN
Dozen young Yale scientists honored for promising mental health research
- August 12, 2015
Brain abnormalities are present even before onset of schizophrenia
Lab Overview
Welcome to the Anticevic Lab:

Our group is interested in cognitive neuroscience of psychiatric illness, with the broad objective of better understanding neural systems involved in cognitive and affective deficits via non-invasive neuroimaging.
Broadly, our group is interested in cognitive neuroscience of psychiatric illness. We seek to better understand, at the neural system level, the mechanisms behind cognitive and affective deficits in neuropsychiatric illness. Specifically, the research in our group focuses on understanding these processes in schizophrenia, bipolar illness and addiction. We use a combination of tools to better understand the underlying systems involved in processing affective stimuli and their interaction with circuits involved in goal-directed cognitive operations such as working memory.
Methodologically, our lab harnesses the combination of task-based, resting-state, pharmacological functional neuroimaging, as well as computational modeling approaches. Combining these approaches allows us to mechanistically understand neural circuit dysfunction in psychiatric disorders. Our experimental approaches depend on the combination of these tools to better understand the mechanistic links between dysfunction at the microcircuit level and complex cognitive and affective disturbances. The overarching objective of the lab is to better characterize the underlying neural circuit dysfunction in complex mental illness such as schizophrenia, with the aim of developing better neural markers and informing rationally-guided pharmacological treatments. The lab is also a close affiliate of the Center for the Translational Neuroscience of Alcoholism (CTNA) and the Division of Neurocognition, Neurocomputation, and Neurogenetics (N3).
Twitter Feed
@anticeviclab Retweeted @AnticevicLabImportant work by @andrewejaffe showing a promising way to map neural gene 🧬 transcriptome alterations in PTSD, which can inform disease-specific differential gene expression. This can map onto neural drug targets that could in turn be tested via pharmacological neuroimaging. https://t.co/pcF1h6ycL17 DAYS AGO
@biorxiv_neursciDecoding shared versus divergent transcriptomic signatures across cortico-amygdala circuitry in PTSD and depressive disorders https://t.co/w38uSv7P0H #biorxiv_neursci7 DAYS AGO
@anticeviclab Retweeted @zenbrainestA giant in the field of neuropharmacology--discovered the role of dopamine receptor subtypes in antipsychotic drug actions
https://t.co/yZerftJOpe https://t.co/uOirxhk26p https://t.co/3f7SJcTU6I7 DAYS AGO
@anticeviclab Retweeted @SaberaTalukder🔥 Hot take 🔥
Domain specific knowledge in machine learning is seriously underrated.
In the coming years it's going to become increasingly important as more people master the tools but not necessarily the domain.14 DAYS AGO
@anticeviclab Retweeted @JuanEugenioIgl1Turning a clinical scan / set of scans into a 1 mm isotropic MP-RAGE that you can easily analyze with FreeSurfer, register, etc. Fun stuff!
https://t.co/BJkuh05EXg
Code available at:
https://t.co/VzAqJME9iF https://t.co/u7OY2EtYjO14 DAYS AGO
@anticeviclab Retweeted @AlPowers7Very excited about @dr_rick_adams 's presentation at Yale MAPs on Thursday: https://t.co/gcRD8hrFwx. The potential for subject-specific parameters of relevance to circuit dysfunction in schizophrenia could be a game-changer. Join us!14 DAYS AGO
Principal Investigator
Alan Anticevic, PhD
Associate Professor of Psychiatry